Dow, S&P 500, Nasdaq futures mixed as AI fervor meets US-Iran uncertainty

🔭 Astrotech's 1,100% rocket ride under fire as short seller calls it "fundamentally uninvestable"

Astrotech Corporation's rally came under pressure after short seller Fugazi Research released a report questioning the company's strategy, revenue base, and corporate governance structure.

The report described the stock as "fundamentally uninvestable" and warned of a potential "99% correction."

Following the report, Astrotech shares fell more than 15% in Wednesday premarket trading as investors reacted to the allegations and reassessed the company's recent surge. Benzinga reports.


🧬 Lilly gains license for Ascidian's gene-editing tech to develop kidney disease drugs

Ascidian Therapeutics announced a licensing agreement with Eli Lilly worth up to $1.9 billion to develop new treatments for rare inherited kidney diseases.

Under the deal, Lilly receives exclusive rights to use Ascidian's RNA exon-editing technology for certain undisclosed kidney disease targets.

The technology is designed to repair faulty genes at the RNA level without permanently modifying a patient's DNA, offering a potentially safer and more flexible approach to genetic medicine.

The agreement highlights continued investment by major pharmaceutical companies in next-generation gene-editing technologies as they seek new treatments for rare and difficult-to-treat diseases. Yahoo Finance reports.


⚛️ INFQ back on radar after UK quantum push; shares jump

Infleqtion shares moved sharply higher late Tuesday as renewed investor interest in the quantum computing sector lifted the stock.

The rally was supported by a recent U.K. quantum technology initiative and broader strength across publicly traded quantum computing companies.

As a relatively new public company, Infleqtion remains a developing story for investors, who are evaluating the value of its government quantum contracts, manufacturing ambitions, and path toward commercialization.

Like many quantum technology firms, Infleqtion faces questions around timing and profitability, as the industry is still in the early stages of commercial adoption.

The stock's move reflects growing investor interest in companies positioned to benefit from long-term advances in quantum computing and related technologies. TechStock² reports.


🔬 Rigetti moves up, but new filings keep quantum trades on edge

Rigetti Computing shares gained 4.9% on Tuesday to close at $26.88, giving the quantum computing company a market capitalization of approximately $9.0 billion.

The stock's latest move came as investors reviewed new insider filings while broader enthusiasm for quantum computing stocks was supported by recent policy developments.

Rigetti remains one of the few publicly traded pure-play quantum computing companies, making it a popular but highly volatile name among investors seeking exposure to the sector.

Quantum computing is still in its early stages, with companies racing to develop systems that use qubits to solve certain problems that are difficult for traditional computers.

The combination of regulatory developments, insider activity, and growing interest in next-generation computing technologies continues to keep quantum stocks in focus. TechStock² reports.


🔗 Corning shares move after AI news

Corning shares surged Tuesday, reversing Monday's decline as investors rotated into companies tied to the optical infrastructure supporting AI data centers.

The stock was last trading at $200.40, up $23.66 on the session, with more than 18 million shares changing hands.

Investor interest is increasingly expanding beyond semiconductor makers to include the broader ecosystem that powers AI infrastructure.

Companies involved in optical fiber, connectivity hardware, networking equipment, glass technologies, and high-speed data transmission are attracting attention as demand grows for the systems that connect thousands of GPUs inside large AI data centers.

The move highlights a broader market trend in which AI-related investment is spreading across the entire data center supply chain, not just chip manufacturers. TechStock² reports.


🎮 GameStop stock jumps after Q1 double beat, $2 billion buyback authorization

GameStop shares moved higher Wednesday after the company reported first-quarter results that exceeded Wall Street expectations on both revenue and earnings, while also announcing a new $2 billion share repurchase program.

The company reported revenue of $835.3 million, topping analyst estimates of $766.64 million.

Earnings came in at 30 cents per share, well ahead of the consensus forecast of 16 cents per share.

GameStop also reported first-quarter net income of $389.6 million, the highest quarterly net income in the company's history.

Operating income reached $143.3 million, marking the strongest first-quarter operating performance ever recorded by the company.

The newly approved $2 billion buyback authorization further boosted investor sentiment, signalling management's confidence in the company's financial position. Benzinga reports.


🧬 TransCode's RNA therapeutic achieves 64% stable disease rate in colorectal cancer Phase 1 study

TransCode Therapeutics announced Wednesday that it has successfully completed the Phase 1a dose-escalation clinical trial of its lead cancer therapeutic candidate, TTX-MC138.

It met its primary safety objectives and demonstrated durable disease stabilization in patients with advanced metastatic cancer. Benzinga reports.

Time (ET) / Report / Period

8:15 AM - ADP employment - May
9:00 AM - Federal Reserve governor Michael Barr speech - N/A
9:45 AM - S&P final U.S. services PMI - May

“The greatest investing error comes not from factors that are informational or analytical, but from those that are psychological.”

– Howard Marks

Sourced in: The Most Important Thing — OakTreeCapital.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.